glp-1 next generation 🚨 HOT OFF THE PRESS: Retatrutide Phase 3 data has arrived — and the obesity medicine world is paying attention. In Lilly's TRIUMPH-1 trial, participants receiving the highest dose achieved an average The GLP-1 Revolution: How Next-Generation

antagonism summarizes peptide GIP antagonists, interventions against K cells or GIP secretion, or specific antibodies either inactivating circulating GIP or GIP receptors

And it's getting expensive

Exenatide, derived from Heloderma lizard venom, exhibits resistance to DPP-4 degradation with a half-life of approximately 24 h [68, 69], and its formulation in poly(lactic-co-glycolic acid) (PLGA) microspheres (Bydureon BCise ) enables once-weekly dosing by prolonging release kinetics [70]

However, these effects were significantly impaired in Sirt1 +/ mice compared with wild-type controls

We just dont know.

If dental work is already needed, these issues can slow healing or increase the risk of complications after procedures